Orthocell (OCC.AX) Stock Price
Orthocell Price
Over the last 16 years Orthocell grew revenue by 24.1% annually, reaching 11.41 M AUD. For Orthocell, the net margin of -122.0% is up versus -594.5% a few years ago. The consensus 12-month price target for Orthocell is 1.26 AUD, about 94.6% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
Orthocell stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Orthocell business model & stock analysis
Frequently asked questions about Orthocell
Analysts currently set an average price target of 1.26 AUD for the Orthocell stock (median: 1.26 AUD), implying +94.6 % versus the latest price. The consensus is based on 5 analyst ratings.
6 analysts currently rate the Orthocell stock: 5 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Orthocell share trades at 0.41 EUR (0.65 AUD).
The revenue of Orthocell is 11.41 M AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Orthocell is -13.91 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Orthocell is currently -12.72. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Orthocell stock.
The price-to-sales ratio (P/S) of Orthocell is currently 15.51. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Orthocell stock.
The Eulerpool Quality Score for Orthocell is 4/10.
The ISIN of Orthocell is AU000000OCC6. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Orthocell is OCC.AX. The ticker symbol is used to trade Orthocell shares on the stock exchange.
Orthocell stock
Orthocell Peer Group
Orthocell FIGI
All fundamentals and in-depth analysis of Orthocell
Our stock analysis for Orthocell stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orthocell. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.